Goldenwell Biotech (GWLL) Change in Cash (2019 - 2025)
Goldenwell Biotech (GWLL) has disclosed Change in Cash for 7 consecutive years, with -$30885.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Change in Cash fell 47.32% year-over-year to -$30885.0, compared with a TTM value of $40868.0 through Sep 2025, up 670.46%, and an annual FY2024 reading of -$3827.0, down 152.9% over the prior year.
- Change in Cash was -$30885.0 for Q3 2025 at Goldenwell Biotech, down from $59381.0 in the prior quarter.
- Across five years, Change in Cash topped out at $158602.0 in Q4 2022 and bottomed at -$145655.0 in Q1 2022.
- Average Change in Cash over 5 years is -$3216.9, with a median of -$19373.0 recorded in 2021.
- The sharpest move saw Change in Cash plummeted 16138.73% in 2021, then surged 3861.37% in 2025.
- Year by year, Change in Cash stood at -$19373.0 in 2021, then surged by 918.68% to $158602.0 in 2022, then plummeted by 73.95% to $41312.0 in 2023, then increased by 8.08% to $44649.0 in 2024, then crashed by 169.17% to -$30885.0 in 2025.
- Business Quant data shows Change in Cash for GWLL at -$30885.0 in Q3 2025, $59381.0 in Q2 2025, and -$32277.0 in Q1 2025.